Navigation Links
Research on wood formation sheds light on plant biology
Date:8/23/2012

Scientists at North Carolina State University have discovered a phenomenon never seen before in plants while studying molecular changes inside tree cells as wood is formed.

In research published online in Proceedings of the National Academy of Sciences the week of Aug. 20, the team found that one member of a family of proteins called transcription factors took control of a cascade of genes involved in forming wood, which includes a substance called lignin that binds fibers together and gives wood its strength.

The controller protein regulated gene expression on multiple levels, preventing abnormal or stunted plant growth. And it did so in a novel way.

The controller, a spliced variant of the SND1 family, was found in the cytoplasm outside the cell nucleus. This is abnormal, because transcription factor proteins are always in the nucleus. But when one of the four other proteins in its family group was present, the spliced variant was carried into the nucleus, where it bound to the family member, creating a new type of molecule that suppressed the expression of a cascade of genes.

"This is nothing that's been observed before in plants," says Dr. Vincent Chiang, co-director of NC State's Forest Biotechnology Group with Dr. Ron Sederoff. Chiang's research team was the first to produce a transgenic tree with reduced lignin. High lignin levels are desirable for lumber, but lignin is removed during the process of making paper or manufacturing biofuels.

Chiang, a professor in the College of Natural Resources, described the team's finding as the long-sought path to understanding the hierarchy of gene regulation for wood formation.


'/>"/>

Contact: Dr. Vincent Chiang
vincent_chiang@ncsu.edu
919-513-0098
North Carolina State University
Source:Eurekalert

Page: 1

Related biology news :

1. Origami inspires research into materials that self-assemble when exposed to light
2. MDA supports Duchenne muscular dystrophy research by University of Nevada School of Medicine
3. Iowa State, Ames Lab researchers study the structure of drug resistance in tuberculosis
4. Lawson researcher sings the baby blues
5. Brazil joins international marine research effort
6. Research identifies mechanism responsible for eye movement disorder
7. Research reveals unique solution to gene regulation
8. Organic study of live pancreatic tissue yields new opportunities for diabetes research
9. ASU awarded $3 million to research solar energy technologies, launch energy Ph.D. program
10. ORNL researchers improve soil carbon cycling models
11. Finding new research frontiers in a single cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology: